Ubs Group Ag Emergent Bio Solutions Inc. Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

A detailed history of Ubs Group Ag transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Ubs Group Ag holds 268,438 shares of EBS stock, worth $2.26 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

268,438

Previous 256,958 4.47%

Holding current value

$2.26 Million

Previous $1.75 Million 27.91%

% of portfolio

0.0%

Previous 0.0%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$5.72 - $14.77 $65,665 - $169,559	11,480 Added 4.47%	268,438 $2.24 Million
Q2 2024 Aug 13, 2024	SELL	$1.86 - $6.98 $54,090 - $202,985	-29,081 Reduced 10.17%	256,958 $1.75 Million
Q1 2024 May 13, 2024	BUY	$1.5 - $3.41 $124,318 - $282,617	82,879 Added 40.79%	286,039 $723,000
Q4 2023 Feb 09, 2024	BUY	$1.82 - $3.16 $207,467 - $360,217	113,993 Added 127.84%	203,160 $487,000
Q3 2023 Nov 09, 2023	SELL	$3.17 - $7.91 $381,617 - $952,237	-120,384 Reduced 57.45%	89,167 $303,000
Q2 2023 Aug 11, 2023	SELL	$7.35 - $13.21 $257,448 - $462,706	-35,027 Reduced 14.32%	209,551 $1.54 Million
Q1 2023 May 12, 2023	BUY	$7.79 - $16.29 $285,160 - $596,311	36,606 Added 17.6%	244,578 $2.53 Million
Q4 2022 Feb 08, 2023	BUY	$11.0 - $21.45 $1.33 Million - $2.6 Million	121,190 Added 139.65%	207,972 $2.46 Million
Q3 2022 Nov 10, 2022	BUY	$20.09 - $35.8 $314,247 - $559,983	15,642 Added 21.99%	86,782 $1.82 Million
Q2 2022 Aug 10, 2022	SELL	$27.42 - $43.63 $19,824 - $31,544	-723 Reduced 1.01%	71,140 $2.21 Million
Q1 2022 May 16, 2022	SELL	$36.48 - $52.22 $3.11 Million - $4.45 Million	-85,131 Reduced 54.23%	71,863 $2.95 Million
Q4 2021 Feb 14, 2022	BUY	$33.11 - $55.01 $2.31 Million - $3.83 Million	69,694 Added 79.83%	156,994 $6.82 Million
Q3 2021 Nov 15, 2021	BUY	$50.07 - $66.05 $2.83 Million - $3.73 Million	56,468 Added 183.15%	87,300 $4.37 Million
Q2 2021 Aug 13, 2021	SELL	$56.61 - $80.46 $1.37 Million - $1.95 Million	-24,194 Reduced 43.97%	30,832 $1.94 Million
Q1 2021 May 12, 2021	BUY	$86.23 - $125.19 $1.79 Million - $2.6 Million	20,793 Added 60.74%	55,026 $5.11 Million
Q4 2020 Feb 11, 2021	SELL	$79.17 - $111.47 $1.77 Million - $2.49 Million	-22,332 Reduced 39.48%	34,233 $3.07 Million
Q3 2020 Nov 12, 2020	SELL	$81.91 - $134.94 $937,787 - $1.54 Million	-11,449 Reduced 16.83%	56,565 $5.84 Million
Q2 2020 Jul 31, 2020	BUY	$54.33 - $89.52 $2.92 Million - $4.82 Million	53,829 Added 379.48%	68,014 $5.38 Million
Q1 2020 May 01, 2020	SELL	$49.34 - $68.76 $2.25 Million - $3.14 Million	-45,648 Reduced 76.29%	14,185 $820,000
Q4 2019 Feb 14, 2020	SELL	$51.21 - $59.06 $2.75 Million - $3.17 Million	-53,744 Reduced 47.32%	59,833 $3.23 Million
Q3 2019 Nov 14, 2019	BUY	$40.6 - $57.2 $3.5 Million - $4.93 Million	86,105 Added 313.43%	113,577 $5.94 Million
Q2 2019 Aug 14, 2019	SELL	$39.92 - $53.86 $539,878 - $728,402	-13,524 Reduced 32.99%	27,472 $1.33 Million
Q1 2019 May 14, 2019	SELL	$48.23 - $66.16 $2.11 Million - $2.9 Million	-43,816 Reduced 51.66%	40,996 $2.07 Million
Q4 2018 Feb 14, 2019	BUY	$55.63 - $73.24 $2.55 Million - $3.35 Million	45,802 Added 117.41%	84,812 $5.03 Million
Q3 2018 Nov 14, 2018	BUY	$52.05 - $66.51 $632,563 - $808,296	12,153 Added 45.25%	39,010 $2.57 Million
Q2 2018 Aug 14, 2018	SELL	$48.33 - $55.64 $2.57 Million - $2.96 Million	-53,164 Reduced 66.44%	26,857 $1.36 Million
Q1 2018 May 15, 2018	BUY	$44.44 - $54.39 $2.31 Million - $2.82 Million	51,895 Added 184.51%	80,021 $4.21 Million
Q4 2017 Feb 14, 2018	SELL	$37.77 - $47.75 $30,404 - $38,438	-805 Reduced 2.78%	28,126 $1.31 Million
Q3 2017 Nov 14, 2017	BUY	$34.14 - $40.45 $358,572 - $424,846	10,503 Added 56.99%	28,931 $1.17 Million
Q2 2017 Aug 14, 2017	SELL	N/A	-15,245 Reduced 45.27%	18,428 $626,000
Q1 2017 Nov 14, 2017	BUY	N/A	33,673	33,673 $978,000

Others Institutions Holding EBS

# of Institutions

160

Shares Held

33.8M

Call Options Held

453K

Put Options Held

931K

View Full List

About Emergent BioSolutions Inc.

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $420M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

More about EBS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account